In his presentation, Professor Pannek highlighted that symptoms that affect bladder or sexual function can have a profound impact on quality of life (QoL). Fifteen percent of people with MS (PwMS) already present with symptoms of neurogenic lower urinary tract dysfunction (NLUTD) at diagnosis. The incidence increases drastically over time, and almost all patients eventually develop NLUTD, which may be manifested by a variety of storage and voiding symptoms. People with MS may suffer from overactive bladders, leading to frequent urination with small amounts, problems emptying all the urine from the bladder, or even complete loss of bladder control. Symptoms of underactive bladder include increased residual urine or urinary retention, and the inability to sense when the bladder is full. In addition, NLUTD can be associated with urinary tract infections and secondary renal damage.
See All 19th State Of The Art Symposium Videos
